Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Bioceres Crop Solutions Corp Market Cap
From what 0 stock analysts predict, the share price for Bioceres Crop Solutions Corp (BIOX) might decrease by 100% in the next year. This is based on a 12-month average estimation for BIOX. Price targets go from $ to $. The majority of stock analysts believe BIOX is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedBIOX 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Bioceres Crop Solutions Corp to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on BIOX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of BIOX.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
N/A
Staff Count
0
Country
Argentina
Sector/Industry
Basic Materials/Agricultural Inputs
CEO
Dr. Federico Trucco Ph.D.
Market Cap
$0
In 2023, BIOX generated $419.4M in revenue, which was a increase of 27.70% from the previous year. This can be seen as a signal that BIOX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Thu, 26 Sep 2024
Sentiment - POSITIVE
Source - Benzinga
Summary - Oversold stocks in the materials sector may offer investment opportunities in undervalued companies.
Why It Matters - Oversold materials stocks indicate potential bargains, signaling a chance for investors to capitalize on undervalued companies and enhance portfolio returns.
Tue, 17 Sep 2024
Sentiment - NEGATIVE
Source - Seeking Alpha
Summary - Bioceres' 4Q24 results showed flat profitability, leading to a 15% stock drop. The company faces rising debt, challenges with HB4 products, and is shifting focus to bio solutions.
Why It Matters - Bioceres' disappointing results and rising debt amid a bear market raise concerns about financial stability and future profitability, impacting investor sentiment and stock confidence.
Tue, 10 Sep 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Bioceres Crop Solutions Corp. (NASDAQ:BIOX) will hold its Q4 2024 earnings conference call on September 10, 2024, at 8:30 AM ET. Key executives will discuss financial results.
Why It Matters - Bioceres Crop Solutions' earnings call provides insights into its financial performance and strategic direction, influencing stock valuation and investor sentiment.
Mon, 09 Sep 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced its financial results for Q4 and fiscal year ending June 30, 2024, focusing on agricultural productivity and climate resilience.
Why It Matters - Bioceres' financial results impact investors by indicating the company's growth potential and resilience in the agricultural sector, crucial for assessing future performance and investment decisions.
Tue, 27 Aug 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will hold a conference call on September 10, 2024, at 8:30 a.m. ET to discuss its Q4 and fiscal year results ending June 30, 2024.
Why It Matters - Bioceres' upcoming earnings call may reveal key financial performance and strategic insights, influencing investor sentiment and stock valuation based on fiscal health and growth prospects.
Wed, 28 Aug 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced that the USDA has favorably completed its Regulatory Status Review for HB4 wheat technology, confirming it poses no increased risk.
Why It Matters - The USDA's favorable review of HB4 wheat boosts Bioceres' growth potential, likely enhancing market confidence and increasing stock value for BIOX.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
